Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue, helped by improved demand for its products and services used in developing therapies. Contract ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Thermo Fisher returned to growth in 4Q 2024 across ... While the Life Sciences Tools and Services industry has gone through a period of unsustainable growth during the pandemic followed by a ...

Barclays raised the firm’s price target on Thermo Fisher (TMO) to $620 from $610 and keeps an Equal Weight rating on the shares. The company’s ...

Thermo Fisher Scientific has launched the Invitrogen Evos S1000 spatial imaging system, which enables researchers to produce ...

Thermo Fisher Scientific (TMO) reports Q4 earnings of ... Bibhu Pattnaik Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

Thermo Fisher Scientific TMO has outperformed the market over the past 15 years by 6.03% on an annualized basis producing an average annual return of 17.98%. Currently, Thermo Fisher Scientific ...

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

(Reuters) -Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies ...